Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Clinica Chimica Acta

Volumn 506, Issue , 2020, Pages 145-148

  Lippi, Giuseppe ^a   Plebani, Mario ^b   Henry, Brandon Michael ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Coronavirus, COVID 19; Platelets; Thrombocytopenia

Indexed keywords

ARTICLE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; HOSPITALIZATION; HUMAN; HYPOXEMIA; MORPHOLOGY; MORTALITY; PLATELET COUNT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; BETACORONAVIRUS; BLOOD; COMPLICATION; ISOLATION AND PURIFICATION; META ANALYSIS; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; PANDEMICS; PLATELET COUNT; PNEUMONIA, VIRAL; RISK FACTORS; THROMBOCYTOPENIA;

EID: 85082406821     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2020.03.022     Document Type: Article

References (22)

1. World Health Organization, Coronavirus disease 2019 (COVID-19) Situation Report – 47, (2020). https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200307-sitrep-47-covid-19.pdf?sfvrsn=27c364a4_2 (accessed March 7, 2020).
2. WHO-China Joint Mission, Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), (2020). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed March 1, 2020).
3. Mattiuzzi, C., Lippi, G., Which lessons shall we learn from the 2019 novel coronavirus outbreak?. Ann. Transl. Med., 8, 2020 (accessed March 8, 2020) http://atm.amegroups.com/post/view/which-lessons-shall-we-learn-from-the-2019-novel-coronavirus-outbreak.
4. Khurana, D., Deoke, S.A., Thrombocytopenia in critically Ill patients: clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization. Indian J. Crit. Care Med. 21 (2017), 861–864, 10.4103/ijccm.IJCCM_279_17.
5. Vanderschueren, S., De Weerdt, A., Malbrain, M., Vankersschaever, D., Frans, E., Wilmer, A., Bobbaers, H., Thrombocytopenia and prognosis in intensive care. Crit. Care Med. 28 (2000), 1871–1876, 10.1097/00003246-200006000-00031.
6. Hui, P., Cook, D.J., Lim, W., Fraser, G.A., Arnold, D.M., The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139 (2011), 271–278, 10.1378/chest.10-2243.
7. Yang, M., Ng, M.H.L., Li, C.K., Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 10 (2005), 101–105, 10.1080/10245330400026170.
8. He, W., Chen, S., Liu, X., Li, Y., Xiao, Z., Zhong, N., Death risk factors of severe acute respiratory syndrome with acute respiratory distress syndrome. Chin. Crit. Care Med. 15 (2003), 336–337.
9. Zou, Z., Yang, Y., Chen, J., Xin, S., Zhang, W., Zhou, X., Mao, Y., Hu, L., Liu, D., Chang, B., Chang, W., Liu, Y., Ma, X., Wang, Y., Liu, X., Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases. Clin. Infect. Dis. 38 (2004), 483–489, 10.1086/380973.
10. Hozo, S.P., Djulbegovic, B., Hozo, I., Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Method., 5, 2005, 13, 10.1186/1471-2288-5-13.
11. Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D.S.C., Du, B., Li, L.-J., Zeng, G., Yuen, K.-Y., Chen, R.-C., Tang, C.-L., Wang, T., Chen, P.-Y., Xiang, J., Li, S.-Y., Wang, J.-L., Liang, Z.-J., Peng, Y.-X., Wei, L., Liu, Y., Hu, Y.-H., Peng, P., Wang, J.-M., Liu, J.-Y., Chen, Z., Li, G., Zheng, Z.-J., Qiu, S.-Q., Luo, J., Ye, C.-J., Zhu, S.-Y., Zhong, N.-S., China medical treatment expert group for covid-19, clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 2020, 10.1056/NEJMoa2002032.
12. C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, B. Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet. 395 (2020) 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.
13. Liu, W., Tao, Z.-W., Lei, W., Ming-Li, Y., Kui, L., Ling, Z., Shuang, W., Yan, D., Jing, L., Liu, H.-G., Ming, Y., Yi, H., Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin. Med. J., 2020, 10.1097/CM9.0000000000000775.
14. Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., Zhang, Z., Wang, L., Peng, L., Chen, L., Qin, Y., Zhao, D., Tan, S., Yin, L., Xu, J., Zhou, C., Jiang, C., Liu, L., Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 63 (2020), 364–374, 10.1007/s11427-020-1643-8.
15. Ruan, Q., Yang, K., Wang, W., Jiang, L., Song, J., Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med., 2020, 10.1007/s00134-020-05991-x.
16. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 10.1001/jama.2020.1585.
17. Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., Yu, T., Wang, Y., Pan, S., Zou, X., Yuan, S., Shang, Y., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respirat. Med., 2020, 10.1016/S2213-2600(20)30079-5.
18. Young, B.E., Ong, S.W.X., Kalimuddin, S., Low, J.G., Tan, S.Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L.W., Mak, T.M., Lau, S.K., Anderson, D.E., Chan, K.S., Tan, T.Y., Ng, T.Y., Cui, L., Said, Z., Kurupatham, L., Chen, M.I.-C., Chan, M., Vasoo, S., Wang, L.-F., Tan, B.H., Lin, R.T.P., Lee, V.J.M., Leo, Y.-S., Lye, D.C., Epidemiologic Features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA, 2020, 10.1001/jama.2020.3204.
19. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, B., Song, B., Gu, X., Guan, L., Wei, T., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., Cao, B., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020.
20. Zarychanski, R., Houston, D.S., Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematol. Am. Soc. Hematol. Educ. Program. 2017 (2017), 660–666.
21. Jolicoeur, P., Lamontagne, L., Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice. Adv. Exp. Med. Biol. 380 (1995), 193–195, 10.1007/978-1-4615-1899-0_33.
22. Lippi, G., Plebani, M., Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin. Chim. Acta, 2020, 10.1016/j.cca.2020.03.004.